PHGDH catalyses the first rate-limiting step of the serine biosynthesis pathway and is highly expressed in certain cancers, such as triple-negative breast cancers (28), melanoma (28), cervical cancer (11), and gliomas (29). The gene discussed is PHGDH; the disease is cancer.